AI & Imaging
Azra AI agents scan EHR data for trial-ready patients
Azra AI said the platform uses real-time EHR data ingestion and agentic AI to identify potential clinical-trial candidates earlier.
Section
All News
Every story we've published, newest first. 318 articles.
Conferences
Philips previews Titanion MR for quantitative 3T imaging
Philips introduced Titanion MR, an ultra-high-gradient 3T MRI system, at ISMRM 2026. The work-in-progress system is designed for quantitative biomarker imaging in applications such as neurology and oncology.
Practice
Study finds physicians leaving practice earlier
AMA researchers surveyed 971 clinically inactive physicians and found newer reasons for leaving practice, including hassle factor, stress, and administrative burden.
Clinical
Fluoride, lead co-exposure linked to lower youth BMD
Researchers analyzed NHANES data from 2,378 U.S. children and adolescents who underwent DEXA scans from 2013 to 2016.
Practice
Pediatric MRI safety events require vigilance, study finds
Researchers reviewed nearly 541,000 pediatric MRI exams across 5 hospitals and found 146 Zone IV safety events. Most caused no serious harm, but 60% involved protocol nonadherence.
Business
TerraPower breaks ground on Ac-225 isotope facility
TerraPower Isotopes has broken ground on a $450M actinium-225 manufacturing facility in Philadelphia. The company said the site will increase global Ac-225 production capacity 20-fold.
Business
Solis adds AI-enabled breast imaging sites in Pennsylvania and Texas
Solis Mammography has opened new breast imaging centers in Doylestown, PA, Houston, Pflugerville, TX, and Corpus Christi, TX. The openings include partnerships with Jefferson Health, HCA Houston Healthcare, St. David’s HealthCare, and Corpus Christi Medical Center.
AI & Imaging
AI or Not reports 95% accuracy in deepfake X-ray benchmark
AI or Not said its detection platform identified 100% of synthetic X-rays in a blinded benchmark using a dataset from a recent Radiology study. The company reported 95% overall accuracy and a 7.8% false-positive rate on authentic X-rays.
Clinical
Stanford project aims to make MR lymphangiography faster
Stanford Medicine received up to $3.9M from ARPA-H to advance MR lymphangiography. Andreas Loening, MD, PhD, will lead work on faster scans, lymphatic-specific contrast agents, and contrast-free flow assessment.
Clinical
Bayer PET tracer meets cardiac amyloidosis endpoints
Bayer reported positive topline phase 3 REVEAL results for I-124 evuzamitide, an investigational PET/CT radiotracer for suspected cardiac amyloidosis. The study met its sensitivity and specificity endpoints.